IMP
Process View
positive regulation of endopeptidase activity
Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of endopeptidase activity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2 | B-cell CLL/lymphoma 2 | 1.000 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.997 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.994 | ||
| BCL2L1 | BCL2-like 1 | 0.993 | Human | |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.960 | ||
| BAX | BCL2-associated X protein | 0.953 | ||
| RB1 | retinoblastoma 1 | 0.914 | ||
| CREBBP | CREB binding protein | 0.905 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.901 | Human | |
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.897 | ||
| PYCARD | PYD and CARD domain containing | 0.839 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.838 | ||
| PSMD11 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 | 0.833 | ||
| BID | BH3 interacting domain death agonist | 0.831 | Mouse | |
| SMAD1 | SMAD family member 1 | 0.822 | Human | |
| POU5F1 | POU class 5 homeobox 1 | 0.815 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.802 | Human Fly | |
| S100B | S100 calcium binding protein B | 0.773 | Human | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.751 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.751 | Rat | |
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.703 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.700 | Human | |
| TP53 | tumor protein p53 | 0.668 | Zebrafish Fly | |
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.663 | Human Fly | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.660 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.654 | Human | |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.622 | ||
| SMAD2 | SMAD family member 2 | 0.605 | Human | |
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.595 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.542 | Human | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.540 | ||
| BCAP31 | B-cell receptor-associated protein 31 | 0.540 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.530 | ||
| SMN1 | survival of motor neuron 1, telomeric | 0.529 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.515 | ||
| S100A6 | S100 calcium binding protein A6 | 0.504 | Human | |
| PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | 0.483 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.467 | ||
| PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0.447 | ||
| PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.427 | ||
| FMR1 | fragile X mental retardation 1 | 0.419 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.405 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.401 | Human | |
| PSMC4 | proteasome (prosome, macropain) 26S subunit, ATPase, 4 | 0.394 | ||
| PSMD7 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 | 0.392 | ||
| SUMO2 | SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) | 0.390 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.377 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.374 | ||
| SP1 | Sp1 transcription factor | 0.368 | ||
| DAXX | death-domain associated protein | 0.356 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.349 | ||
| HCK | hemopoietic cell kinase | 0.348 | Human | |
| SOCS1 | suppressor of cytokine signaling 1 | 0.348 | ||
| PSMD13 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 | 0.346 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.318 | ||
| S100A14 | S100 calcium binding protein A14 | 0.312 | ||
| BMP2 | bone morphogenetic protein 2 | 0.309 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.298 | ||
| S100A1 | S100 calcium binding protein A1 | 0.297 | Human | |
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.292 | ||
| PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 | 0.291 | ||
| NCL | nucleolin | 0.268 | ||
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.264 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.255 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.239 | Human Mouse | |
| NCK1 | NCK adaptor protein 1 | 0.239 | ||
| HMGB2 | high mobility group box 2 | 0.228 | Human | |
| COL4A1 | collagen, type IV, alpha 1 | 0.228 | Human | |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.226 | Mouse | |
| PSMC2 | proteasome (prosome, macropain) 26S subunit, ATPase, 2 | 0.224 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.223 | ||
| AR | androgen receptor | 0.219 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.216 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.203 | ||
| PML | promyelocytic leukemia | 0.202 | Mouse | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.198 | ||
| S100A4 | S100 calcium binding protein A4 | 0.191 | Human | |
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.189 | ||
| UCHL5 | ubiquitin carboxyl-terminal hydrolase L5 | 0.180 | ||
| SMAD7 | SMAD family member 7 | 0.177 | Human | |
| PSMD3 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 | 0.177 | ||
| USP14 | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) | 0.176 | ||
| HMGB1 | high mobility group box 1 | 0.169 | ||
| PSMD1 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 | 0.164 | ||
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.162 | Human Mouse | |
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.156 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.153 | Zebrafish | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.152 | ||
| PSMD10 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 | 0.149 | ||
| TMSB10 | thymosin beta 10 | 0.148 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.148 | ||
| RAD23B | RAD23 homolog B (S. cerevisiae) | 0.148 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.147 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.145 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.143 | ||
| NMI | N-myc (and STAT) interactor | 0.136 | ||
| PSME3 | proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki) | 0.134 | ||
| RXRA | retinoid X receptor, alpha | 0.134 | ||
| HDAC1 | histone deacetylase 1 | 0.132 | ||
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.129 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.129 | ||
| SMAD4 | SMAD family member 4 | 0.127 | Human | |
| WDR5 | WD repeat domain 5 | 0.126 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.125 | ||
| ITK | IL2-inducible T-cell kinase | 0.124 | ||
| EZR | ezrin | 0.122 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.119 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.119 | Human | |
| PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.118 | Human Mouse | |
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.117 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.116 | ||
| PSMC6 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 | 0.115 | ||
| RARA | retinoic acid receptor, alpha | 0.115 | ||
| GAS7 | growth arrest-specific 7 | 0.114 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.114 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.113 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.113 | Human | |
| ANXA2 | annexin A2 | 0.112 | ||
| MAPK6 | mitogen-activated protein kinase 6 | 0.111 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.111 | ||
| PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 | 0.110 | ||
| PSMA7 | proteasome (prosome, macropain) subunit, alpha type, 7 | 0.108 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.106 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.099 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.099 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.098 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.098 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.098 | Rat | |
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.097 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.097 | ||
| S100A2 | S100 calcium binding protein A2 | 0.096 | Human | |
| EIF4G1 | eukaryotic translation initiation factor 4 gamma, 1 | 0.095 | ||
| EIF3E | eukaryotic translation initiation factor 3, subunit E | 0.095 | ||
| S100A11 | S100 calcium binding protein A11 | 0.094 | Human | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.093 | Fly | |
| GSK3B | glycogen synthase kinase 3 beta | 0.091 | ||
| NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 0.089 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.086 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.086 | ||
| PSMC3 | proteasome (prosome, macropain) 26S subunit, ATPase, 3 | 0.086 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.085 | ||
| SMAD6 | SMAD family member 6 | 0.083 | Human | |
| C9orf89 | chromosome 9 open reading frame 89 | 0.082 | ||
| PELP1 | proline, glutamate and leucine rich protein 1 | 0.081 | ||
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.080 | ||
| AREG | amphiregulin | 0.079 | ||
| ASB2 | ankyrin repeat and SOCS box containing 2 | 0.078 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.075 | ||
| EGFR | epidermal growth factor receptor | 0.075 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.074 | ||
| SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 0.074 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.073 | ||
| ANXA4 | annexin A4 | 0.073 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.073 | ||
| NAA10 | N(alpha)-acetyltransferase 10, NatA catalytic subunit | 0.071 | ||
| COL4A5 | collagen, type IV, alpha 5 | 0.071 | Human | |
| RAD21 | RAD21 homolog (S. pombe) | 0.071 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.071 | ||
| BECN1 | beclin 1, autophagy related | 0.070 | ||
| PTGES3 | prostaglandin E synthase 3 (cytosolic) | 0.070 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.069 | ||
| SP100 | SP100 nuclear antigen | 0.069 | ||
| BAD | BCL2-associated agonist of cell death | 0.068 | ||
| S100A12 | S100 calcium binding protein A12 | 0.068 | Human | |
| ESR1 | estrogen receptor 1 | 0.068 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.068 | Human | |
| FH | fumarate hydratase | 0.067 | ||
| EDF1 | endothelial differentiation-related factor 1 | 0.066 | ||
| FKBP3 | FK506 binding protein 3, 25kDa | 0.066 | ||
| PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 | 0.065 | ||
| HSPA9 | heat shock 70kDa protein 9 (mortalin) | 0.064 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.063 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.063 | ||
| PTMA | prothymosin, alpha | 0.063 | ||
| JAK3 | Janus kinase 3 | 0.062 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.062 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.062 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.062 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.062 | Human | |
| VDAC1 | voltage-dependent anion channel 1 | 0.062 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.061 | ||
| HTT | huntingtin | 0.061 | ||
| USP9Y | ubiquitin specific peptidase 9, Y-linked | 0.061 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.061 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.061 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.060 | ||
| SKIL | SKI-like oncogene | 0.060 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.059 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.058 | Human | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.058 | Human | |
| GDF5 | growth differentiation factor 5 | 0.058 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.058 | ||
| CSTA | cystatin A (stefin A) | 0.058 | ||
| SPRR2A | small proline-rich protein 2A | 0.058 | ||
| SMAD5 | SMAD family member 5 | 0.057 | Human | |
| PAX3 | paired box 3 | 0.057 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.057 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.057 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.057 | ||
| PSMA1 | proteasome (prosome, macropain) subunit, alpha type, 1 | 0.056 | ||
| MED31 | mediator complex subunit 31 | 0.055 | ||
| CPE | carboxypeptidase E | 0.055 | ||
| PTEN | phosphatase and tensin homolog | 0.054 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.053 | ||
| SMAD9 | SMAD family member 9 | 0.053 | Human | |
| PSIP1 | PC4 and SFRS1 interacting protein 1 | 0.052 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.051 | ||
| PYDC2 | pyrin domain containing 2 | 0.051 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.051 | ||
| FOXF1 | forkhead box F1 | 0.051 | ||
| HDAC2 | histone deacetylase 2 | 0.050 | ||
| TANK | TRAF family member-associated NFKB activator | 0.049 | ||
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.049 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.049 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.049 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.048 | ||
| YY1 | YY1 transcription factor | 0.048 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.048 | ||
| EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 0.048 | ||
| HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 | 0.048 | ||
| ESRRG | estrogen-related receptor gamma | 0.048 | ||
| ROMO1 | reactive oxygen species modulator 1 | 0.048 | ||
| MEFV | Mediterranean fever | 0.047 | ||
| FAM46A | family with sequence similarity 46, member A | 0.047 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.047 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.047 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.047 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.047 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.046 | Human Fly | |
| PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.046 | ||
| NAP1L1 | nucleosome assembly protein 1-like 1 | 0.046 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.046 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.046 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.045 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.045 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.045 | ||
| ONECUT1 | one cut homeobox 1 | 0.044 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.044 | Mouse | |
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.044 | Human | |
| DAB2IP | DAB2 interacting protein | 0.044 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.044 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.044 | ||
| FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 0.044 | ||
| BBC3 | BCL2 binding component 3 | 0.044 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.043 | ||
| TMX2 | thioredoxin-related transmembrane protein 2 | 0.042 | ||
| LAMB1 | laminin, beta 1 | 0.042 | ||
| CDK5 | cyclin-dependent kinase 5 | 0.041 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.041 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.041 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.041 | ||
| MCRS1 | microspherule protein 1 | 0.041 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.041 | ||
| INHBB | inhibin, beta B | 0.041 | ||
| HR | hairless homolog (mouse) | 0.040 | ||
| S100A9 | S100 calcium binding protein A9 | 0.040 | ||
| C4orf14 | chromosome 4 open reading frame 14 | 0.040 | ||
| NOG | noggin | 0.040 | ||
| CBX3 | chromobox homolog 3 | 0.040 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.039 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.039 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.039 | ||
| PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | 0.039 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.039 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.039 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.038 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.038 | ||
| ABI1 | abl-interactor 1 | 0.038 | ||
| HIC1 | hypermethylated in cancer 1 | 0.038 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.038 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.038 | ||
| GORAB | golgin, RAB6-interacting | 0.037 | ||
| PKM2 | pyruvate kinase, muscle | 0.037 | ||
| PRDX5 | peroxiredoxin 5 | 0.037 | ||
| CALD1 | caldesmon 1 | 0.037 | ||
| RPL11 | ribosomal protein L11 | 0.037 | ||
| IL13RA1 | interleukin 13 receptor, alpha 1 | 0.036 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.036 | ||
| SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.036 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.036 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.036 | ||
| NAF1 | nuclear assembly factor 1 homolog (S. cerevisiae) | 0.036 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.036 | Human | |
| NID1 | nidogen 1 | 0.036 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.036 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.036 | ||
| CXXC5 | CXXC finger protein 5 | 0.035 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.035 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.035 | ||
| SYK | spleen tyrosine kinase | 0.035 | ||
| FSTL1 | follistatin-like 1 | 0.035 | ||
| CCND1 | cyclin D1 | 0.035 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.035 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.035 | ||
| TMEM30A | transmembrane protein 30A | 0.035 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.034 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.034 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.034 | ||
| AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | 0.034 | ||
| PTN | pleiotrophin | 0.034 | ||
| MLL2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 0.033 | ||
| BMP4 | bone morphogenetic protein 4 | 0.033 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.033 | ||
| POLD3 | polymerase (DNA-directed), delta 3, accessory subunit | 0.033 | ||
| IFI35 | interferon-induced protein 35 | 0.033 | ||
| RPS29 | ribosomal protein S29 | 0.033 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.033 | ||
| BCL2A1 | BCL2-related protein A1 | 0.033 | Human | |
| CAV2 | caveolin 2 | 0.033 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.033 | ||
| RPS27L | ribosomal protein S27-like | 0.033 | ||
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.033 | ||
| SF3B4 | splicing factor 3b, subunit 4, 49kDa | 0.032 | ||
| SNW1 | SNW domain containing 1 | 0.032 | ||
| JUN | jun proto-oncogene | 0.032 | ||
| SELL | selectin L | 0.032 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.032 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.032 | ||
| FOXF2 | forkhead box F2 | 0.031 | ||
| TXNL1 | thioredoxin-like 1 | 0.031 | ||
| SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.031 | ||
| FERMT2 | fermitin family member 2 | 0.031 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.031 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.031 | ||
| DLC1 | deleted in liver cancer 1 | 0.031 | ||
| CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 0.031 | ||
| C20orf24 | chromosome 20 open reading frame 24 | 0.031 | ||
| MARCKSL1 | MARCKS-like 1 | 0.031 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.031 | ||
| TXN | thioredoxin | 0.030 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.030 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.030 | ||
| NUCB2 | nucleobindin 2 | 0.030 | ||
| TRMT2A | TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae) | 0.030 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.030 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.030 | ||
| SRI | sorcin | 0.030 | ||
| GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.030 | ||
| HIF1AN | hypoxia inducible factor 1, alpha subunit inhibitor | 0.030 | ||
| ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | 0.029 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.029 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.029 | ||
| STRAP | serine/threonine kinase receptor associated protein | 0.029 | ||
| C17orf37 | chromosome 17 open reading frame 37 | 0.029 | ||
| S100P | S100 calcium binding protein P | 0.029 | Human | |
| HMGN2 | high mobility group nucleosomal binding domain 2 | 0.029 | ||
| EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | 0.029 | ||
| ING2 | inhibitor of growth family, member 2 | 0.029 | ||
| SLC10A2 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | 0.029 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.029 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.029 | Mouse | |
| TAF1C | TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa | 0.029 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.029 | ||
| ZNF420 | zinc finger protein 420 | 0.028 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.028 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.028 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.028 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.028 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.028 | ||
| RYBP | RING1 and YY1 binding protein | 0.028 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.028 | Human | |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.028 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.028 | ||
| PSMA3 | proteasome (prosome, macropain) subunit, alpha type, 3 | 0.028 | ||
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.028 | ||
| RNF144B | ring finger protein 144B | 0.028 | ||
| CAST | calpastatin | 0.028 | ||
| PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | 0.028 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.027 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.027 | ||
| FPR2 | formyl peptide receptor 2 | 0.027 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.027 | ||
| SET | SET nuclear oncogene | 0.027 | ||
| NDUFA9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa | 0.027 | ||
| CCNE1 | cyclin E1 | 0.027 | ||
| ANXA1 | annexin A1 | 0.027 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.027 | ||
| CLU | clusterin | 0.027 | ||
| RNR2 | l-rRNA | 0.027 | ||
| TBX2 | T-box 2 | 0.027 | ||
| DBN1 | drebrin 1 | 0.027 | ||
| ACVR1B | activin A receptor, type IB | 0.027 | Human | |
| BAG1 | BCL2-associated athanogene | 0.027 | ||
| THBS1 | thrombospondin 1 | 0.027 | ||
| LMNA | lamin A/C | 0.027 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.027 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.026 | Human | |
| KIAA0101 | KIAA0101 | 0.026 | ||
| UBL4A | ubiquitin-like 4A | 0.026 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.026 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.026 | ||
| MEX3C | mex-3 homolog C (C. elegans) | 0.026 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.026 | Human | |
| EP300 | E1A binding protein p300 | 0.026 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.026 | ||
| HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 | 0.026 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.026 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.026 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.026 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.026 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.026 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.026 | ||
| NRP1 | neuropilin 1 | 0.026 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.026 | ||
| PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.026 | ||
| AHNAK | AHNAK nucleoprotein | 0.025 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.025 | ||
| OAS1 | 2',5'-oligoadenylate synthetase 1, 40/46kDa | 0.025 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.025 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.025 | ||
| CHST3 | carbohydrate (chondroitin 6) sulfotransferase 3 | 0.025 | ||
| AMOTL2 | angiomotin like 2 | 0.025 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.025 | ||
| HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.025 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.025 | ||
| CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | 0.024 | ||
| EGR1 | early growth response 1 | 0.024 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.024 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.024 | ||
| GPR65 | G protein-coupled receptor 65 | 0.024 | ||
| NGFR | nerve growth factor receptor | 0.024 | ||
| CXXC1 | CXXC finger protein 1 | 0.024 | ||
| UBE2Q1 | ubiquitin-conjugating enzyme E2Q family member 1 | 0.024 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.024 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.024 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.024 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.024 | Human | |
| PDGFC | platelet derived growth factor C | 0.024 | ||
| IL8 | interleukin 8 | 0.024 | ||
| FOXC1 | forkhead box C1 | 0.024 | Human | |
| HOXD1 | homeobox D1 | 0.024 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.024 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.024 | ||
| ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | 0.024 | ||
| IDH3A | isocitrate dehydrogenase 3 (NAD+) alpha | 0.024 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.024 | ||
| GDF6 | growth differentiation factor 6 | 0.024 | Human | |
| ACAN | aggrecan | 0.024 | ||
| RHOJ | ras homolog gene family, member J | 0.024 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.024 | ||
| KDM5D | lysine (K)-specific demethylase 5D | 0.024 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.024 | ||
| GTF2I | general transcription factor IIi | 0.023 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.023 | ||
| DUT | deoxyuridine triphosphatase | 0.023 | ||
| PGR | progesterone receptor | 0.023 | ||
| PHB | prohibitin | 0.023 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.023 | ||
| MAFIP | MAFF interacting protein | 0.023 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.023 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.023 | Human | |
| PSMA6 | proteasome (prosome, macropain) subunit, alpha type, 6 | 0.023 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.023 | ||
| HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 0.023 | ||
| UBE2D2 | ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) | 0.023 | ||
| CCKBR | cholecystokinin B receptor | 0.023 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.023 | ||
| INADL | InaD-like (Drosophila) | 0.023 | ||
| WT1 | Wilms tumor 1 | 0.023 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.023 | ||
| PBK | PDZ binding kinase | 0.023 | ||
| HOXD9 | homeobox D9 | 0.023 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.023 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.022 | ||
| LMO4 | LIM domain only 4 | 0.022 | ||
| S100A10 | S100 calcium binding protein A10 | 0.022 | Human | |
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.022 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.022 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.022 | Human Fly | |
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.022 | Human | |
| CARD6 | caspase recruitment domain family, member 6 | 0.022 | ||
| LDHB | lactate dehydrogenase B | 0.022 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.022 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.022 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.022 | ||
| TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.022 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.022 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.022 | ||
| CA6 | carbonic anhydrase VI | 0.022 | ||
| BTRC | beta-transducin repeat containing | 0.022 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.022 | ||
| IRF3 | interferon regulatory factor 3 | 0.022 | ||
| HOXD13 | homeobox D13 | 0.022 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.022 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.022 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.022 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.022 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.022 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.021 | ||
| BRCA1 | breast cancer 1, early onset | 0.021 | ||
| CLTCL1 | clathrin, heavy chain-like 1 | 0.021 | ||
| SOX8 | SRY (sex determining region Y)-box 8 | 0.021 | Human | |
| NDUFB10 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa | 0.021 | ||
| FXR2 | fragile X mental retardation, autosomal homolog 2 | 0.021 | ||
| PIM1 | pim-1 oncogene | 0.021 | ||
| STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase | 0.021 | ||
| FGF10 | fibroblast growth factor 10 | 0.021 | ||
| ARRB2 | arrestin, beta 2 | 0.021 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.021 | ||
| SRGN | serglycin | 0.021 | ||
| FHL2 | four and a half LIM domains 2 | 0.021 | ||
| S100A8 | S100 calcium binding protein A8 | 0.021 | ||
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 0.021 | ||
| TNC | tenascin C | 0.021 | ||
| PITX2 | paired-like homeodomain 2 | 0.021 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.021 | ||
| RPS4Y1 | ribosomal protein S4, Y-linked 1 | 0.021 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.021 | ||
| LCN2 | lipocalin 2 | 0.021 | ||
| DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 | 0.021 | ||
| SNX33 | sorting nexin 33 | 0.021 | ||
| HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.021 | ||
| BMP8A | bone morphogenetic protein 8a | 0.021 | Human | |
| DOCK8 | dedicator of cytokinesis 8 | 0.021 | ||
| HOXB13 | homeobox B13 | 0.021 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.021 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.021 | ||
| MCAM | melanoma cell adhesion molecule | 0.021 | ||
| RPL5 | ribosomal protein L5 | 0.021 | ||
| PDLIM5 | PDZ and LIM domain 5 | 0.021 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.021 | ||
| EFNB3 | ephrin-B3 | 0.020 | ||
| SOX5 | SRY (sex determining region Y)-box 5 | 0.020 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.020 | ||
| DNM1L | dynamin 1-like | 0.020 | ||
| RBMX | RNA binding motif protein, X-linked | 0.020 | ||
| ATM | ataxia telangiectasia mutated | 0.020 | ||
| PARP10 | poly (ADP-ribose) polymerase family, member 10 | 0.020 | ||
| IRF9 | interferon regulatory factor 9 | 0.020 | ||
| OBFC2A | oligonucleotide/oligosaccharide-binding fold containing 2A | 0.020 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.020 | ||
| CARD16 | caspase recruitment domain family, member 16 | 0.020 | ||
| ASB7 | ankyrin repeat and SOCS box containing 7 | 0.020 | ||
| DDB2 | damage-specific DNA binding protein 2, 48kDa | 0.020 | ||
| GPR109B | G protein-coupled receptor 109B | 0.020 | ||
| AFF1 | AF4/FMR2 family, member 1 | 0.020 | ||
| NSFL1C | NSFL1 (p97) cofactor (p47) | 0.020 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.020 | ||
| AQP9 | aquaporin 9 | 0.020 | ||
| ARRB1 | arrestin, beta 1 | 0.020 | ||
| TUSC2 | tumor suppressor candidate 2 | 0.020 | ||
| CCDC59 | coiled-coil domain containing 59 | 0.020 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.020 | ||
| MSX1 | msh homeobox 1 | 0.020 | ||
| BMP7 | bone morphogenetic protein 7 | 0.020 | Human | |
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.020 | ||
| ARHGAP29 | Rho GTPase activating protein 29 | 0.020 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.020 | ||
| OTX2 | orthodenticle homeobox 2 | 0.020 | ||
| WARS | tryptophanyl-tRNA synthetase | 0.020 | ||
| ASB6 | ankyrin repeat and SOCS box containing 6 | 0.020 | ||
| ACBD3 | acyl-CoA binding domain containing 3 | 0.020 | ||
| MYOF | myoferlin | 0.020 | ||
| GBX2 | gastrulation brain homeobox 2 | 0.020 | ||
| ERH | enhancer of rudimentary homolog (Drosophila) | 0.020 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.020 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.020 | ||
| PTF1A | pancreas specific transcription factor, 1a | 0.020 | ||
| TBKBP1 | TBK1 binding protein 1 | 0.019 | ||
| BEST2 | bestrophin 2 | 0.019 | ||
| KRT5 | keratin 5 | 0.019 | ||
| FPR1 | formyl peptide receptor 1 | 0.019 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.019 | ||
| PTPRS | protein tyrosine phosphatase, receptor type, S | 0.019 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.019 | ||
| ALX4 | ALX homeobox 4 | 0.019 | ||
| NR2E1 | nuclear receptor subfamily 2, group E, member 1 | 0.019 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.019 | Human | |
| IL1R2 | interleukin 1 receptor, type II | 0.019 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.019 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.019 | ||
| EREG | epiregulin | 0.019 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.019 | Human | |
| MRPL4 | mitochondrial ribosomal protein L4 | 0.019 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.019 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.019 | ||
| TBCB | tubulin folding cofactor B | 0.019 | ||
| TALDO1 | transaldolase 1 | 0.019 | ||
| TFCP2 | transcription factor CP2 | 0.019 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.019 | ||
| MAGEA2 | melanoma antigen family A, 2 | 0.019 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.019 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.019 | Human | |
| CARD10 | caspase recruitment domain family, member 10 | 0.019 | ||
| HOXC8 | homeobox C8 | 0.019 | ||
| EPHA2 | EPH receptor A2 | 0.019 | ||
| CRABP1 | cellular retinoic acid binding protein 1 | 0.019 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.019 | ||
| SOX17 | SRY (sex determining region Y)-box 17 | 0.019 | Human | |
| ANTXR2 | anthrax toxin receptor 2 | 0.019 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.019 | ||
| PCDHA4 | protocadherin alpha 4 | 0.019 | ||
| H2AFV | H2A histone family, member V | 0.019 | ||
| GPR4 | G protein-coupled receptor 4 | 0.019 | ||
| KRT8 | keratin 8 | 0.019 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.019 | ||
| MT1A | metallothionein 1A | 0.019 | ||
| VENTX | VENT homeobox homolog (Xenopus laevis) | 0.019 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.019 | ||
| ADRM1 | adhesion regulating molecule 1 | 0.019 | ||
| ARID3C | AT rich interactive domain 3C (BRIGHT-like) | 0.018 | ||
| APP | amyloid beta (A4) precursor protein | 0.018 | ||
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | 0.018 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.018 | ||
| BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | 0.018 | ||
| PRRX2 | paired related homeobox 2 | 0.018 | ||
| RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.018 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.018 | ||
| PF4 | platelet factor 4 | 0.018 | ||
| NRTN | neurturin | 0.018 | ||
| OSTF1 | osteoclast stimulating factor 1 | 0.018 | ||
| AXIN1 | axin 1 | 0.018 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.018 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.018 | ||
| CNN3 | calponin 3, acidic | 0.018 | ||
| LEMD3 | LEM domain containing 3 | 0.018 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.018 | Human | |
| AURKA | aurora kinase A | 0.018 | ||
| MAX | MYC associated factor X | 0.018 | ||
| ME2 | malic enzyme 2, NAD(+)-dependent, mitochondrial | 0.018 | ||
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.018 | ||
| ORMDL2 | ORM1-like 2 (S. cerevisiae) | 0.018 | ||
| KIAA1967 | KIAA1967 | 0.018 | ||
| NLRP1 | NLR family, pyrin domain containing 1 | 0.018 | ||
| LY6D | lymphocyte antigen 6 complex, locus D | 0.018 | ||
| MYOD1 | myogenic differentiation 1 | 0.018 | ||
| PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.018 | ||
| RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 0.018 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.018 | ||
| FIBP | fibroblast growth factor (acidic) intracellular binding protein | 0.018 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.018 | ||
| TK1 | thymidine kinase 1, soluble | 0.018 | ||
| FOXG1 | forkhead box G1 | 0.018 | Human | |
| GSC | goosecoid homeobox | 0.018 | ||
| ACVR1 | activin A receptor, type I | 0.018 | Human | |
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.018 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.018 | ||
| ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.018 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.018 | ||
| JAK1 | Janus kinase 1 | 0.018 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.018 | ||
| FOXB1 | forkhead box B1 | 0.018 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.018 | ||
| PARP4 | poly (ADP-ribose) polymerase family, member 4 | 0.018 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.018 | ||
| CLDN18 | claudin 18 | 0.018 | ||
| KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | 0.018 | ||
| VIM | vimentin | 0.017 | ||
| DAZAP2 | DAZ associated protein 2 | 0.017 | ||
| TPT1 | tumor protein, translationally-controlled 1 | 0.017 | ||
| PROX1 | prospero homeobox 1 | 0.017 | ||
| EVI2A | ecotropic viral integration site 2A | 0.017 | ||
| POLR2J | polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa | 0.017 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.017 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.017 | ||
| SCARB2 | scavenger receptor class B, member 2 | 0.017 | ||
| RBM7 | RNA binding motif protein 7 | 0.017 | ||
| TBX21 | T-box 21 | 0.017 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.017 | ||
| ETF1 | eukaryotic translation termination factor 1 | 0.017 | ||
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.017 | ||
| MPZL2 | myelin protein zero-like 2 | 0.017 | ||
| FBXO33 | F-box protein 33 | 0.017 | ||
| MEN1 | multiple endocrine neoplasia I | 0.017 | Mouse | |
| CAPN2 | calpain 2, (m/II) large subunit | 0.017 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.017 | ||
| RUNX2 | runt-related transcription factor 2 | 0.017 | ||
| LMNB1 | lamin B1 | 0.017 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.017 | ||
| AIM2 | absent in melanoma 2 | 0.017 | ||
| VNN2 | vanin 2 | 0.017 | ||
| EGR3 | early growth response 3 | 0.017 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.017 | ||
| PPA1 | pyrophosphatase (inorganic) 1 | 0.017 | ||
| GAS1 | growth arrest-specific 1 | 0.017 | ||
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 0.017 | ||
| ZFY | zinc finger protein, Y-linked | 0.017 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.017 | ||
| NRP2 | neuropilin 2 | 0.017 | ||
| BCL2L2 | BCL2-like 2 | 0.017 | Human | |
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.017 | ||
| SH2B2 | SH2B adaptor protein 2 | 0.017 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.017 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.017 | ||
| ZBTB7A | zinc finger and BTB domain containing 7A | 0.017 | ||
| ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.017 | ||
| PROCR | protein C receptor, endothelial | 0.017 | ||
| BABAM1 | BRISC and BRCA1 A complex member 1 | 0.017 | ||
| CREB3 | cAMP responsive element binding protein 3 | 0.017 | ||
| ZBTB25 | zinc finger and BTB domain containing 25 | 0.017 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.017 | ||
| SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 0.017 | ||
| PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | 0.017 | ||
| FDXR | ferredoxin reductase | 0.017 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.017 | ||
| HMGN1 | high mobility group nucleosome binding domain 1 | 0.017 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.017 | ||
| TRIM27 | tripartite motif containing 27 | 0.017 | ||
| USP9X | ubiquitin specific peptidase 9, X-linked | 0.017 | ||
| RUSC1 | RUN and SH3 domain containing 1 | 0.017 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.017 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.017 | ||
| STK17B | serine/threonine kinase 17b | 0.017 | ||
| SPNS1 | spinster homolog 1 (Drosophila) | 0.017 | ||
| NPPC | natriuretic peptide C | 0.017 | ||
| CSNK1D | casein kinase 1, delta | 0.017 | ||
| OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.017 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.017 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.017 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.017 | ||
| ZBTB10 | zinc finger and BTB domain containing 10 | 0.017 | ||
| PSEN1 | presenilin 1 | 0.017 | ||
| AIMP2 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 | 0.017 | ||
| MRPL24 | mitochondrial ribosomal protein L24 | 0.017 | ||
| ITGB5 | integrin, beta 5 | 0.016 | ||
| GATA4 | GATA binding protein 4 | 0.016 | ||
| HIST2H3C | histone cluster 2, H3c | 0.016 | ||
| OTP | orthopedia homeobox | 0.016 | ||
| MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 0.016 | ||
| CLEC14A | C-type lectin domain family 14, member A | 0.016 | ||
| HIP1 | huntingtin interacting protein 1 | 0.016 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.016 | ||
| NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 0.016 | ||
| YAP1 | Yes-associated protein 1 | 0.016 | ||
| BHLHE22 | basic helix-loop-helix family, member e22 | 0.016 | ||
| SNAI2 | snail homolog 2 (Drosophila) | 0.016 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.016 | ||
| PPP1R1B | protein phosphatase 1, regulatory (inhibitor) subunit 1B | 0.016 | ||
| PLAT | plasminogen activator, tissue | 0.016 | ||
| EN1 | engrailed homeobox 1 | 0.016 | ||
| GATA5 | GATA binding protein 5 | 0.016 | ||
| SALL3 | sal-like 3 (Drosophila) | 0.016 | ||
| INSR | insulin receptor | 0.016 | ||
| CHSY1 | chondroitin sulfate synthase 1 | 0.016 | ||
| EDN1 | endothelin 1 | 0.016 | ||
| CLTB | clathrin, light chain B | 0.016 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.016 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.016 | Human | |
| GSPT1 | G1 to S phase transition 1 | 0.016 | ||
| NDUFA11 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa | 0.016 | ||
| MYH10 | myosin, heavy chain 10, non-muscle | 0.016 | ||
| PPIF | peptidylprolyl isomerase F | 0.016 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.016 | ||
| HOXA9 | homeobox A9 | 0.016 | ||
| CRLF1 | cytokine receptor-like factor 1 | 0.016 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.016 | ||
| EFNB2 | ephrin-B2 | 0.016 | ||
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.016 | ||
| TMEM205 | transmembrane protein 205 | 0.016 | ||
| GDNF | glial cell derived neurotrophic factor | 0.016 |